CLONING PALLID A MUTANT AFFECTING INNER EAR AND BLEEDING
克隆 PALLID A 突变体影响内耳和出血
基本信息
- 批准号:3330185
- 负责人:
- 金额:$ 16.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-08-01 至 1995-07-31
- 项目状态:已结题
- 来源:
- 关键词:artificial chromosomes ataxia blood coagulation cell line chromosome walking computer assisted sequence analysis disease /disorder model embryo /fetus tissue /cell culture fungal genetics gene complementation gene mutation genetic library genetic markers hemostasis laboratory mouse linkage mapping melanocyte melanosomes molecular cloning mutant otocyst /otolith pigmentation disorders platelet disorder platelets polymerase chain reaction pulsed field gel electrophoresis recombinant DNA restriction mapping southern blotting transfection
项目摘要
The goal of this project is to clone a gene that complements the mouse
pallid mutant. This mutant is one of a group of eleven genetically
distinct mutants affecting coat color and bleeding time. These effects are
mediated through alterations in melanosomes and platelet dense granules,
both of which are present, but defective in the mutant mice. Some of the
mutants, including pallid, also have some effects on the function of a
third organelle, the lysosome. Pallid is one of three mutants that affect
the inner ear, and the mutants display ataxia because the otoliths,
required for balance, are missing. Cloning the normal gene will allow
analysis of the normal function of the gene in all parts of its complex
phenotype, both at the molecular and cellular level, and analysis of the
mutant phenotype.
The proposed approach to cloning this gene involves identifying the
molecular marker closest to the pallid mutation on mouse chromosome 2.
This will be done using an interspecific backcross (C57BL/6J-pa a1/pa a1 X
M. spretus-+ A/+ A)F1 X C57BL/6J-pa a1/pa a1, that has already produced 123
progeny. Preliminary data suggest that beta2-microglobulin is a very close
marker. A YAC clone containing the selected marker will be obtained and
used to start the walk to pallid. The ends of the YAC will be cloned and
sequenced to identify overlapping YACs. Backcross animals containing
recombination breakpoints will be identified and used first to determine
the direction of the walk and later to monitor progress between the
starting point and the target. YAC clones overlapping the interval between
the recombination breakpoints flanking the pallid mutation will be
candidates for the desired clones.
To determine whether any of the genes on the YAC are expressed in
megakaryocytes (platelet precursors) or in skin, cDNA libraries from skin
and bone marrow cells will be made in a 'fragmenting vector' which contains
a selectable yeast marker not present in the YAC and a yeast telomere. The
libraries will be transformed into yeast cells containing the candidate YAC
and recombinants between individual cDNAs and genes on the YAC will be
selected. This will allow identification of one or more candidate genes,
as regions between the candidate gene and the telomere will be deleted in
the recombinant YACs, being replaced by vector sequences. Experiments to
detect the function of the locus involve transformation of DNA from the
candidate YAC or its cosmid subclones into bone marrow cells and
reintroduction of these cells into mice to determine whether the fraction
of platelets with filled dense granules is increased. To determine whether
the pigment dilution can be corrected, transgenic mice will be made by
injecting the same constructs into fertilized eggs homozygous for the
mutant.
这个项目的目标是克隆一种与小鼠互补的基因
苍白的变种人。这个突变体是由11个基因组成的群体中的一个
影响毛色和出血时间的不同突变体。这些影响是
通过黑素小体和血小板致密颗粒的改变,
这两种基因都存在,但在突变小鼠中是有缺陷的。其中一些
突变体,包括苍白的,也有一些影响的功能
第三细胞器,溶酶体。苍白是影响人类健康的三个突变体之一
内耳和突变体表现出共济失调,因为耳石,
平衡所必需的,都缺失了。克隆正常基因将使
基因在其复合体各部分的正常功能分析
在分子和细胞水平上的表型,以及对
突变表型。
建议的克隆该基因的方法包括识别
与小鼠2号染色体上苍白突变最接近的分子标记。
这将使用种间回交(C57BL/6J-pa A1/pa A1 X)来完成
Spretus-+A/+A)F1×C57BL/6J-pa A1/pa A1,已产生123个
后代。初步数据表明,β2-微球蛋白是一种非常接近
记号笔。将获得包含所选标记的YAC克隆
用来开始走向苍白。YAC的末端将被克隆并
测序以识别重叠的YAC。回交动物包含
重组断点将首先被识别和使用,以确定
行走的方向,并在稍后监视
起点和目标。YAC克隆重叠的间隔
苍白突变两侧的重组断裂点将是
所需克隆的候选者。
为了确定YAC上的任何基因是否在
巨核细胞(血小板前体)或皮肤中,来自皮肤的cDNA文库
骨髓细胞将在一种含有以下物质的“碎片化载体”中制造
YAC中不存在的可选择酵母标记和酵母端粒。这个
文库将转化为含有候选YAC的酵母细胞
而YAC上单个cDNA和基因之间的重组体将是
被选中了。这将允许识别一个或多个候选基因,
因为候选基因和端粒之间的区域将在
重组的YAC被载体序列取代。实验以实现
检测与DNA转化有关的基因座的功能
候选YAC或其粘粒亚克隆进入骨髓细胞并
将这些细胞重新引入小鼠体内,以确定该组分是否
填充致密颗粒的血小板数量增加。以确定是否
色素稀释可以纠正,转基因小鼠将通过
将相同的结构注射到纯合子受精卵中
变种人。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROSEMARY W ELLIOTT其他文献
ROSEMARY W ELLIOTT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROSEMARY W ELLIOTT', 18)}}的其他基金
CONGENIC STRAINS FOR GENES AFFECTING COLON TUMORS
影响结肠肿瘤的基因同源菌株
- 批准号:
2103329 - 财政年份:1994
- 资助金额:
$ 16.11万 - 项目类别:
CONGENIC STRAINS FOR GENES AFFECTING COLON TUMORS
影响结肠肿瘤的基因同源菌株
- 批准号:
2008395 - 财政年份:1994
- 资助金额:
$ 16.11万 - 项目类别:
CONGENIC STRAINS FOR GENES AFFECTING COLON TUMORS
影响结肠肿瘤的基因同源菌株
- 批准号:
2103328 - 财政年份:1994
- 资助金额:
$ 16.11万 - 项目类别:
CLONING PALLID A MUTANT AFFECTING INNER EAR AND BLEEDING
克隆 PALLID A 突变体影响内耳和出血
- 批准号:
2201211 - 财政年份:1992
- 资助金额:
$ 16.11万 - 项目类别:
CLONING PALLID A MUTANT AFFECTING INNER EAR AND BLEEDING
克隆 PALLID A 突变体影响内耳和出血
- 批准号:
3330186 - 财政年份:1992
- 资助金额:
$ 16.11万 - 项目类别:
相似海外基金
How exercise improves ataxia in SCA6
运动如何改善 SCA6 的共济失调
- 批准号:
479005 - 财政年份:2023
- 资助金额:
$ 16.11万 - 项目类别:
Operating Grants
Exploratoin of Nrf2 activators that potentiate chaperone-mediated autophagy and are useful for the treatment of spinocrebellar ataxia
探索增强伴侣介导的自噬并可用于治疗脊髓小脑共济失调的 Nrf2 激活剂
- 批准号:
23K06161 - 财政年份:2023
- 资助金额:
$ 16.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Defining the role of Tox3 in congenital cerebellar hypoplasia and ataxia
定义 Tox3 在先天性小脑发育不全和共济失调中的作用
- 批准号:
10799992 - 财政年份:2023
- 资助金额:
$ 16.11万 - 项目类别:
Genome-wide dysregulation of R-loops in Ataxia Telangiectasia neurological pathogenesis
共济失调毛细血管扩张症神经发病机制中 R 环的全基因组失调
- 批准号:
10607414 - 财政年份:2023
- 资助金额:
$ 16.11万 - 项目类别:
Identifying the molecular mechanisms of GEMIN5 mutations in a novel cerebellar ataxia syndrome
鉴定新型小脑共济失调综合征中 GEMIN5 突变的分子机制
- 批准号:
10753403 - 财政年份:2023
- 资助金额:
$ 16.11万 - 项目类别:
Project 2: Therapeutic Gene Editing for Friedreich's Ataxia
项目 2:弗里德赖希共济失调的治疗性基因编辑
- 批准号:
10668768 - 财政年份:2023
- 资助金额:
$ 16.11万 - 项目类别:
Molecular Pathogenesis of spinocerebellar ataxia type 12
12 型脊髓小脑共济失调的分子发病机制
- 批准号:
10579736 - 财政年份:2023
- 资助金额:
$ 16.11万 - 项目类别:
The Impact of Vitamin D on mTOR Signaling, Seizures, and Motor Behavior in a Mouse Model of Hyperactive mTOR Induced Epilepsy and Ataxia
维生素 D 对 mTOR 过度活跃诱发癫痫和共济失调小鼠模型中 mTOR 信号传导、癫痫发作和运动行为的影响
- 批准号:
10754319 - 财政年份:2023
- 资助金额:
$ 16.11万 - 项目类别:
Pathological Mechanisms of Immune-Mediated Cerebellar Ataxia with Associated Sez6L2 Autoantibodies
免疫介导的小脑共济失调与相关 Sez6L2 自身抗体的病理机制
- 批准号:
10740682 - 财政年份:2023
- 资助金额:
$ 16.11万 - 项目类别: